Atlas Capital Advisors LLC Teva Pharmaceutical Industries LTD Transaction History

Atlas Capital Advisors LLC

$656 Billion
Q3 2024

A detailed history of Atlas Capital Advisors LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 43,119 shares of TEVA stock, worth $966,727. This represents 0.12% of its overall portfolio holdings.

Number of Shares

43,119

Previous 43,891 1.76%

Holding current value

$966,727

Previous $713 Million 8.94%

% of portfolio

0.12%

Previous 0.09%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$15.81 - $18.96 $12,205 - $14,637	-772 Reduced 1.76%	43,119 $777 Million
Q2 2024 Jul 29, 2024	BUY	$12.78 - $17.4 $1,904 - $2,592	149 Added 0.34%	43,891 $713 Million
Q1 2024 Apr 15, 2024	BUY	$10.67 - $14.43 $453,496 - $613,303	42,502 Added 3427.58%	43,742 $617 Million
Q2 2023 Aug 15, 2023	SELL	$7.2 - $9.47 $148,946 - $195,905	-20,687 Reduced 94.34%	1,240 $9.34 Million
Q3 2022 Nov 08, 2022	BUY	$6.86 - $11.95 $63,455 - $110,537	9,250 Added 72.97%	21,927 $177 Million
Q1 2022 May 11, 2022	BUY	$7.33 - $9.39 $14,564 - $18,657	1,987 Added 18.59%	12,677 $119 Million
Q4 2021 Feb 01, 2022	BUY	$7.9 - $10.19 $21,085 - $27,197	2,669 Added 33.28%	10,690 $85.6 Million
Q1 2021 May 10, 2021	SELL	$10.34 - $12.81 $46,064 - $57,068	-4,455 Reduced 35.71%	8,021 $92,000
Q2 2020 Jul 28, 2020	SELL	$8.12 - $13.12 $5,074 - $8,200	-625 Reduced 4.77%	12,476 $153,000
Q1 2020 May 04, 2020	BUY	$6.69 - $13.45 $87,164 - $175,240	13,029 Added 18095.83%	13,101 $117,000
Q3 2019 Nov 01, 2019	SELL	$6.16 - $9.6 $43,243 - $67,392	-7,020 Reduced 98.98%	72 $0
Q2 2019 Jul 25, 2019	SELL	$8.12 - $15.72 $207,474 - $401,661	-25,551 Reduced 78.27%	7,092 $0
Q1 2019 Apr 29, 2019	SELL	$15.58 - $20.01 $8,724 - $11,205	-560 Reduced 1.69%	32,643 $0
Q4 2018 Jan 29, 2019	BUY	$14.59 - $23.84 $104,158 - $170,193	7,139 Added 27.39%	33,203 $511,000
Q3 2018 Nov 09, 2018	SELL	$21.06 - $25.65 $200,343 - $244,008	-9,513 Reduced 26.74%	26,064 $0
Q2 2018 Jul 30, 2018	SELL	$16.77 - $24.71 $46,469 - $68,471	-2,771 Reduced 7.23%	35,577 $0
Q1 2018 Apr 18, 2018	BUY	$16.68 - $22.07 $639,644 - $846,340	38,348 New	38,348 $0

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Account

Atlas Capital Advisors LLC Teva Pharmaceutical Industries LTD Transaction History